With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia||Boston Children's Hospital / Sara Canovas Nunes, PhD||Young Investigator Grants||2020||Massachusetts|
|Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting||The Johns Hopkins University School of Medicine / Eric Schafer||Young Investigator Grants||2010||Maryland|
|Pre-clinical Evaluation of LSD1 Inhibitors for the Treatment of Pediatric Ewing sarcoma: Defining the Biomarkers of Sensitivity and Mechanisms of Resistance||Research Institute at Nationwide Children's Hospital / Kathleen Pishas, PhD||Young Investigator Grants||2016||Ohio|
|Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy||Dana-Farber Cancer Institute / Yana Pikman, MD||Young Investigator Grants||2014||Massachusetts|
|Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).||University of California San Francisco / Michelle Hermiston, MD, PhD||Young Investigator Grants||2009||California|
|The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma||Duke University / Michael Armstrong||Young Investigator Grants||2011||North Carolina|
|Development of Novel Biomarkers for Immunotherapy in Neuroblastoma||Columbia Institute for Cancer Genetics / Shuobo Boboila, PhD||Young Investigator Grants||2017||New York|
|Defining the Mechanism by which LIN28B acts as an Oncogene in Neuroblastoma||Children's Hospital of Philadelphia / Robert Schnepp, MD, PhD||Young Investigator Grants||2013||Pennsylvania|
|MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis||Stanford University / Feng Pan, PhD||Young Investigator Grants||2019||California|
|Functional Dissection of Oncogenic Enhancers in T-ALL||Columbia University / Daniel Herranz, PhD||Young Investigator Grants||2015||New York|